A phase 1 clinical trial of an experimental vaccine primed the immune system using a unique approach in order to prevent HIV. The promising results, announced in February by the International AIDS Vaccine Initiative (IAVI) and Scripps Research, the vaccine showed success in stimulating production of rare immune cells needed to generate antibodies against the […]
The post First Human Trial of HIV Vaccine Produced Immune Response in 97% of Volunteers appeared first on Good News Network.
Scrivi un commento
Devi accedere, per commentare.